Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Axon Enterprise vs. Chewy: Do Customers of Police or Pets Make One Stock a Better Buy in 2026?

Axon's 33% revenue surge commands a 67x forward multiple, while Chewy's steady 6% growth trades at less than half that valuation.

Axon Enterprise vs. Chewy: Do Customers of Police or Pets Make One Stock a Better Buy in 2026?

Published August 7, 2026 · Category: Finance

Overview

Choosing between a high-growth technology powerhouse and a steady consumer leader requires a look at whether you prefer rapid innovation or predictable recurring revenue. Axon Enterprise Inc (NASDAQ:AXON) and Chewy Inc (NYSE:CHWY) offer very different paths.

Axon provides mission-critical hardware and software for law enforcement, making it a vital infrastructure play for public safety. Chewy dominates the digital pet supply market by focusing on high-frequency consumable goods. While their industries differ, both companies utilize technology to build deep competitive moats in their respective sectors.

Details

Axon Enterprise operates as a leader among defense stocks by providing an integrated ecosystem of Taser energy devices, body-worn cameras, and cloud-based evidence management software. The company primarily serves federal, state, and local law enforcement agencies, but it is expanding its reach into fire, EMS, and commercial security markets. This strategy creates a sticky business model where hardware sales lead to long-term software subscriptions for data storage and analysis.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.